Subglandular Breast Augmentation with Textured, Anatomic, Cohesive Silicone Implants: A Review of 440 Consecutive Patients

Thursday, May 3, 2012: 4:30 PM
Roberto Tutino, MD1, Adeel Khan, HBSc2, Jamil Ahmad, MD, FRCSC3 and Frank Lista, MD, FRCSC3, (1)Plastic and Reconstructive Surgery, University of Toronto, Toronto, ON, Canada, (2)Medicine, University of Ottawa, Ottawa, ON, Canada, (3)The Plastic Surgery Clinic, Mississauga, ON, Canada
Goals/Purpose: The Allergan Style 410 implant is a textured, anatomic, cohesive silicone breast implant. Recently, concerns with late seroma have been reported in patients with these textured implants. Despite the widespread use of the Style 410 implant in both Europe and Canada, limited data exists regarding long-term outcomes and no specific data is available regarding the incidence of late seroma. The purpose of this study was to investigate outcomes using the Style 410 implant for primary subglandular breast augmentation in a consecutive series by a single surgeon.

Methods/Technique: A retrospective chart review was performed identifying all patients who underwent primary subglandular breast augmentation with the Style 410 implant. Patient demographics and clinical characteristics were documented, as well as implant specifications. Complications including delayed wound healing, infection, seroma, hematoma, capsular contracture, flipping, and reoperations were examined.

Results/Complications: Between 2002 and 2011, 440 consecutive patients were identified. The average patient age at the time of surgery was 35 years old (range 17 to 62 years) and the average body mass index was 22.3 kg/m2. The average implant volume was 385 cc (range 215 to 775 cc). 18.2% of patients experienced a complication and 8.6% required reoperation. The most frequent indication for reoperation was hematoma (2.7% of patients). Capsular contracture developed in 5.6% of patients. Flipping of the implant occurred in 3.6% of breasts but was largely managed nonoperatively. Seroma occurred in 1.8% of breasts; 0.7% occurred 3 months or more after surgery.

Conclusion: To our knowledge, this is the largest reported series of primary subglandular breast augmentation performed using the Style 410 implant. Our study expands the existing literature describing the safety profile of this device and its potential complications. This knowledge will assist plastic surgeons in counseling their patients when deciding the most appropriate approach to breast augmentation.

Back to: R&F Session 2
<< Previous Abstract | Next Abstract >>